Loading…

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer

Whether or not tumor response to chemotherapy-sensitized radiation therapy (CTRT) for head and neck cancer leads to an improved outcome is unknown. Forty patients who received preoperative cisplatin plus simultaneous radiotherapy for operable stage III and IV head and neck cancer were reviewed retro...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 1997-11, Vol.174 (5), p.527-531
Main Authors: D. Goodman, Martin, Tarnoff, Michael, Kain, Michael, J. Slotman, Gus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Whether or not tumor response to chemotherapy-sensitized radiation therapy (CTRT) for head and neck cancer leads to an improved outcome is unknown. Forty patients who received preoperative cisplatin plus simultaneous radiotherapy for operable stage III and IV head and neck cancer were reviewed retrospectively regarding clinical demographics, staging, and survival status. Twenty-one (57%) patients had a histologic complete response (HCR) and 16 (43%) had a partial (PR) (9) or clinical complete (7) response (CCR). Tumor response of N 1 versus N 2–3 nodal disease showed 6 (75%) HCR and 4 (25%). Fiveyear disease-free survival overall was 82% for HCR versus 38% for PR/CCR ( P < 0.05). Disease specific 5-year survival was 100% for HCR versus 27% for PR/CCR ( P
ISSN:0002-9610
1879-1883
DOI:10.1016/S0002-9610(97)00151-7